|
1
|
Savastano E, Perez-Sanchez V, Arrue B, Ollero A. High-Performance Morphing Wing for Large-Scale Bio-Inspired Unmanned Aerial Vehicles. IEEE Robot Autom Lett 2022. [DOI: 10.1109/lra.2022.3185389] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
Affiliation(s)
- E. Savastano
- University of Seville. GRVC Robotics Lab. Camino de los Descubrimientos S/N., Seville, Spain
| | - V. Perez-Sanchez
- University of Seville. GRVC Robotics Lab. Camino de los Descubrimientos S/N., Seville, Spain
| | - B.C. Arrue
- University of Seville. GRVC Robotics Lab. Camino de los Descubrimientos S/N., Seville, Spain
| | - A. Ollero
- University of Seville. GRVC Robotics Lab. Camino de los Descubrimientos S/N., Seville, Spain
| |
Collapse
|
|
2
|
Alvarado Miranda A, Lara Medina FU, Arce C, Castañeda-Soto N, Cano Blanco C, Aguilar Ponce JL, Bargallo Rocha E, Perez-Sanchez V. Phase II open, single-arm trial: Cisplatin combined with paclitaxel and doxorubicin in operable or locally advanced triple-negative breast cancer. J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.15_suppl.1135] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
|
3
|
Arce C, Duenas-Gonzalez A, Mohar A, Lara Medina FU, Perez-Sanchez V, Bargallo Rocha E. Randomized, double blind, phase II trial: Epigenetic therapy (valproic acid and hydralazine) plus chemotherapy versus placebo plus neoadjuvant chemotherapy in operable and locally advanced breast cancer. J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.15_suppl.e13550] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|